8-K
Current Report
KALA BIO, Inc. Filed Acc 0001558370-22-010589
Acquisition or sale completed · Exit or restructuring costs · Delisting notice · Other events
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.05 Costs associated with exit or disposal activities
- Item 3.01 Notice of delisting or failure to meet a listing standard
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading kala-20220708x8k.htm…